Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 51.05
-0.55 (-1.07%)
Jul 30, 2026, 3:39 PM HKT
Nanjing Leads Biolabs Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Nanjing Leads Biolabs stock has a consensus rating of "Buy" and an average price target of $99.73. The average 1-year stock price forecast is 95.36% higher than the current stock price, while the lowest is $79.06 (+54.87%) and the highest is $108.90 (+113.32%).
Price Target: $99.73 (+95.36%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nanjing Leads Biolabs stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Hold Maintains $62.00 → $79.00 | Hold | Maintains | $62.00 → $79.00 | +54.75% | Jul 21, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $108.00 | Buy | Maintains | $108.00 | +111.56% | Jul 13, 2026 |
Unknown Analyst GF Securities No rating | GF Securities | Buy Maintains $110.96 | Buy | Maintains | $110.96 | +117.36% | Apr 28, 2026 |
Unknown Analyst Orient Securities No rating | Orient Securities | Buy Maintains $81.01 → $103.06 | Buy | Maintains | $81.01 → $103.06 | +101.88% | Apr 21, 2026 |
Unknown Analyst Huafu Securities No rating | Huafu Securities | Buy Maintains $101.90 → $140.75 | Buy | Maintains | $101.90 → $140.75 | +175.71% | Apr 15, 2026 |
Financial Forecast
Revenue This Year
230.54M
from 177.26M
Increased by 30.06%
Revenue Next Year
484.14M
from 230.54M
Increased by 110.00%
EPS This Year
-0.89
from -1.03
EPS Next Year
-0.57
from -0.89
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.